519 related articles for article (PubMed ID: 16997946)
1. Global map of growth-regulated gene expression in Burkholderia pseudomallei, the causative agent of melioidosis.
Rodrigues F; Sarkar-Tyson M; Harding SV; Sim SH; Chua HH; Lin CH; Han X; Karuturi RK; Sung K; Yu K; Chen W; Atkins TP; Titball RW; Tan P
J Bacteriol; 2006 Dec; 188(23):8178-88. PubMed ID: 16997946
[TBL] [Abstract][Full Text] [Related]
2. Interrogation of the Burkholderia pseudomallei genome to address differential virulence among isolates.
Challacombe JF; Stubben CJ; Klimko CP; Welkos SL; Kern SJ; Bozue JA; Worsham PL; Cote CK; Wolfe DN
PLoS One; 2014; 9(12):e115951. PubMed ID: 25536074
[TBL] [Abstract][Full Text] [Related]
3. A proteasome inhibitor produced by Burkholderia pseudomallei modulates intracellular growth.
Wagley S; Vanaporn M; Rinchai D; Conejero L; Lertmemongkolchai G; Bancroft GJ; Titball RW
Microb Pathog; 2017 Jun; 107():175-180. PubMed ID: 28323151
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide expression analysis of Burkholderia pseudomallei infection in a hamster model of acute melioidosis.
Tuanyok A; Tom M; Dunbar J; Woods DE
Infect Immun; 2006 Oct; 74(10):5465-76. PubMed ID: 16988221
[TBL] [Abstract][Full Text] [Related]
5. Role of RelA and SpoT in Burkholderia pseudomallei virulence and immunity.
Müller CM; Conejero L; Spink N; Wand ME; Bancroft GJ; Titball RW
Infect Immun; 2012 Sep; 80(9):3247-55. PubMed ID: 22778096
[TBL] [Abstract][Full Text] [Related]
6. Polysaccharides and virulence of Burkholderia pseudomallei.
Sarkar-Tyson M; Thwaite JE; Harding SV; Smither SJ; Oyston PCF; Atkins TP; Titball RW
J Med Microbiol; 2007 Aug; 56(Pt 8):1005-1010. PubMed ID: 17644705
[TBL] [Abstract][Full Text] [Related]
7. Antibodies against
Zimmerman SM; Dyke JS; Jelesijevic TP; Michel F; Lafontaine ER; Hogan RJ
Infect Immun; 2017 Aug; 85(8):. PubMed ID: 28507073
[No Abstract] [Full Text] [Related]
8. Virulence of the Melioidosis Pathogen Burkholderia pseudomallei Requires the Oxidoreductase Membrane Protein DsbB.
McMahon RM; Ireland PM; Sarovich DS; Petit G; Jenkins CH; Sarkar-Tyson M; Currie BJ; Martin JL
Infect Immun; 2018 May; 86(5):. PubMed ID: 29440370
[TBL] [Abstract][Full Text] [Related]
9. Whole-genome comparative analysis of Malaysian
Ghazali AK; Eng SA; Khoo JS; Teoh S; Hoh CC; Nathan S
Microb Genom; 2021 Feb; 7(2):. PubMed ID: 33565959
[No Abstract] [Full Text] [Related]
10. The core and accessory genomes of Burkholderia pseudomallei: implications for human melioidosis.
Sim SH; Yu Y; Lin CH; Karuturi RK; Wuthiekanun V; Tuanyok A; Chua HH; Ong C; Paramalingam SS; Tan G; Tang L; Lau G; Ooi EE; Woods D; Feil E; Peacock SJ; Tan P
PLoS Pathog; 2008 Oct; 4(10):e1000178. PubMed ID: 18927621
[TBL] [Abstract][Full Text] [Related]
11. Development of novel animal infection models for the study of acute and chronic Burkholderia pseudomallei pulmonary infections.
van Schaik E; Tom M; DeVinney R; Woods DE
Microbes Infect; 2008 Oct; 10(12-13):1291-9. PubMed ID: 18707015
[TBL] [Abstract][Full Text] [Related]
12. The Burkholderia pseudomallei Δasd mutant exhibits attenuated intracellular infectivity and imparts protection against acute inhalation melioidosis in mice.
Norris MH; Propst KL; Kang Y; Dow SW; Schweizer HP; Hoang TT
Infect Immun; 2011 Oct; 79(10):4010-8. PubMed ID: 21807903
[TBL] [Abstract][Full Text] [Related]
13. Transcriptome analysis of Burkholderia pseudomallei T6SS identifies Hcp1 as a potential serodiagnostic marker.
Chieng S; Mohamed R; Nathan S
Microb Pathog; 2015 Feb; 79():47-56. PubMed ID: 25616255
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the Burkholderia pseudomallei K96243 capsular polysaccharide I coding region.
Cuccui J; Milne TS; Harmer N; George AJ; Harding SV; Dean RE; Scott AE; Sarkar-Tyson M; Wren BW; Titball RW; Prior JL
Infect Immun; 2012 Mar; 80(3):1209-21. PubMed ID: 22252864
[TBL] [Abstract][Full Text] [Related]
15. Type III secretion system cluster 3 is required for maximal virulence of Burkholderia pseudomallei in a hamster infection model.
Warawa J; Woods DE
FEMS Microbiol Lett; 2005 Jan; 242(1):101-8. PubMed ID: 15621426
[TBL] [Abstract][Full Text] [Related]
16. A model of immunity to Burkholderia pseudomallei: unique responses following immunization and acute lethal infection.
Ulett GC; Labrooy JT; Currie BJ; Barnes JL; Ketheesan N
Microbes Infect; 2005; 7(11-12):1263-75. PubMed ID: 16027024
[TBL] [Abstract][Full Text] [Related]
17. Rapid DNA vaccination against Burkholderia pseudomallei flagellin by tattoo or intranasal application.
Lankelma JM; Wagemakers A; Birnie E; Haak BW; Trentelman JJA; Weehuizen TAF; Ersöz J; Roelofs JJTH; Hovius JW; Wiersinga WJ; Bins AD
Virulence; 2017 Nov; 8(8):1683-1694. PubMed ID: 28323523
[TBL] [Abstract][Full Text] [Related]
18. Identification of a regulatory cascade controlling Type III Secretion System 3 gene expression in Burkholderia pseudomallei.
Sun GW; Chen Y; Liu Y; Tan GY; Ong C; Tan P; Gan YH
Mol Microbiol; 2010 May; 76(3):677-89. PubMed ID: 20345664
[TBL] [Abstract][Full Text] [Related]
19. Characterization of New Virulence Factors Involved in the Intracellular Growth and Survival of Burkholderia pseudomallei.
Moule MG; Spink N; Willcocks S; Lim J; Guerra-Assunção JA; Cia F; Champion OL; Senior NJ; Atkins HS; Clark T; Bancroft GJ; Cuccui J; Wren BW
Infect Immun; 2015 Dec; 84(3):701-10. PubMed ID: 26712202
[TBL] [Abstract][Full Text] [Related]
20. Attenuated virulence and protective efficacy of a Burkholderia pseudomallei bsa type III secretion mutant in murine models of melioidosis.
Stevens MP; Haque A; Atkins T; Hill J; Wood MW; Easton A; Nelson M; Underwood-Fowler C; Titball RW; Bancroft GJ; Galyov EE
Microbiology (Reading); 2004 Aug; 150(Pt 8):2669-2676. PubMed ID: 15289563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
